Fatemeh Haddadi | Pharmaceutical Biotechnology | Best Researcher Award

Published on by Top Pharmaceutical

Dr. Fatemeh Haddadi | Pharmaceutical Biotechnology | Best Researcher Award

University of Zabol | Iran

Dr. Fatemeh Haddadi is a distinguished Iranian scientist and academic, recognized for her pioneering contributions to plant biotechnology, nanobiotechnology, genetic engineering, and molecular genetics. She earned her Bachelor of Science in Plant Biology from the University of Zabol, followed by both her Master’s and Ph.D. degrees in Plant Biotechnology from Universiti Putra Malaysia. Over the years, she has established herself as an influential figure in academia and research, combining advanced molecular methods with applied biotechnology to address agricultural and biomedical challenges.Dr. Haddadi began her academic career as a Special Graduate Research Assistant at Universiti Putra Malaysia, where she actively contributed to groundbreaking research in plant tissue culture and molecular biology. Upon returning to Iran, she joined the University of Zabol as an Assistant Professor, where she continues to teach and supervise both undergraduate and postgraduate students in subjects such as genetics, molecular genetics, genetic engineering, molecular biology, animal biotechnology, and bioinformatics. Her mentorship has guided dozens of graduate students, helping to shape the next generation of biotechnologists.In addition to her academic roles, Dr. Haddadi serves as the Head of Zand Biotechnology Company, a knowledge-based enterprise specializing in biotechnology and genetic engineering innovations. Under her leadership, the company has developed several advanced biotechnological products, including DNA isolation kits from gel, blood, and plants, which have achieved Technology Readiness Level (TRL) 7 recognition by Iran’s national technology assessment authority. Her dedication to translational research bridges the gap between laboratory discovery and industrial application, emphasizing practical solutions for real-world scientific needs.Dr. Haddadi’s innovative spirit has been recognized with several prestigious accolades, including the Khwarizmi Award, multiple medals from the PRPI Invention, Research and Innovation Exhibition, and national awards for knowledge-based products and scientific entrepreneurship. Her scientific influence extends through an impressive portfolio of peer-reviewed publications, including research on micropropagation of strawberry, Agrobacterium-mediated transformation, and the development of gold nanoparticle-based biosensors for molecular detection and gene transformation.

Profile: Google Scholar

Featured Publications

Haddadi, F., Abd Aziz, M., Saleh, G., Abd Rashid, A., & Kamaladini, H. (n.d.). Micropropagation of strawberry cv. Camarosa: Prolific shoot regeneration from in vitro shoot tips using thidiazuron with N6-benzylamino-purine. HortScience, 45(3), 453–456.

Khodavirdipour, A., Haddadi, F., & Keshavarzi, S. (n.d.). Chromium supplementation; negotiation with diabetes mellitus, hyperlipidemia and depression. Journal of Diabetes & Metabolic Disorders, 19(1), 585–595.

Ahmadi, S., Kamaladini, H., Haddadi, F., & Sharifmoghadam, M. R. (n.d.). Thiol-capped gold nanoparticle biosensors for rapid and sensitive visual colorimetric detection of Klebsiella pneumoniae. Journal of Fluorescence, 28(4), 987–998.

Haddadi, F., Abd Aziz, M., Abdullah, S. N. A., Tan, S. G., & Kamaladini, H. (n.d.). An efficient Agrobacterium-mediated transformation of strawberry cv. Camarosa by a dual plasmid system. Molecules, 20(3), 3647–3666.

Haddadi, F., Abd Aziz, M., Kamaladini, H., & Ravanfar, S. A. (n.d.). Thidiazuron- and zeatin-induced high-frequency shoot regeneration from leaf and shoot-tip explants of strawberry. HortTechnology, 23(3), 276–281.

Ravanfar, S. A., Abd Aziz, M., Abd Kadir, M., Abd Rashid, A., & Haddadi, F. (n.d.). In vitro adventitious shoot regeneration and acclimatisation of Brassica oleracea subsp. italica cv. Green Marvel. African Journal of Biotechnology, 10(29), 5614–5619.

Osmani Bojd, M., Kamaladini, H., Haddadi, F., & Vaseghi, A. (n.d.). Thiolated AuNP probes and multiplex PCR for molecular detection of Staphylococcus epidermidis. Molecular and Cellular Probes, 34, 30–36.

Basavaraj Vastrad | Pharmaceutical Biotechnology | Best Innovation Award

Published on by Top Pharmaceutical

Dr. Basavaraj Vastrad | Pharmaceutical Biotechnology | Best Innovation Award

Associate Professor at KLE College of Pharmacy | India

Dr. Basavaraj Vastrad is a distinguished researcher in biochemistry, pharmaceutical biotechnology, and bioinformatics, with expertise spanning drug discovery, biomarker identification, molecular biology, and microbial techniques. His academic journey and scientific contributions reflect a strong commitment to advancing medical and pharmaceutical sciences. He has made significant strides in bioinformatics-driven research, particularly in understanding neurodegenerative and metabolic diseases through next-generation sequencing and computational biology approaches. With a strong foundation in microbiology, tissue culture, and molecular techniques, Dr. Vastrad bridges experimental science with computational tools. His research has resulted in impactful publications, addressing global health challenges and advancing translational medicine.

Publication Profile 

Google Scholar

Education 

Dr. Basavaraj Vastrad earned his Ph.D. in Biochemistry from Kuvempu University, where he focused on antibiotic production and optimization using solid-state fermentation. He holds an M. Pharm in Pharmaceutical Biotechnology from J.S.S. College of Pharmacy, Ootacamund, affiliated with The Tamilnadu Dr. M.G.R Medical University, where he gained expertise in microbial, molecular, and tissue culture techniques. He began his academic foundation with a B. Pharmacy degree from K.L.E’s College of Pharmacy under RGUHS, Bangalore. Earlier, he completed his P.U.C-II at Karnataka Science College, Dharwad, and his S.S.L.C. at Karnataka High College, Dharwad, establishing a solid base in science and medicine.

Experience 

Dr. Basavaraj Vastrad has extensive research experience in pharmaceutical biotechnology, biochemistry, and bioinformatics. His M. Pharm work encompassed microbial assays, enzyme characterization, fermentation technology, cytotoxicity studies, antiviral and antioxidant assays, and tissue culture methods. During his doctoral program, he investigated solid-state fermentation for antibiotic production using agricultural residues, optimizing growth conditions and characterizing bioactive compounds through advanced analytical methods. His expertise extends to next-generation sequencing, microarray analysis, and biomarker discovery, contributing to translational research in neurodegenerative and metabolic diseases. Through bioinformatics-driven projects, Dr. Vastrad has made critical discoveries in molecular pathways and therapeutic targets, resulting in several impactful publications.

Awards and Honors 

Dr. Basavaraj Vastrad has been recognized for his contributions to pharmaceutical biotechnology, bioinformatics, and biomedical research. His work on disease biomarker identification and next-generation sequencing analysis has earned appreciation in the scientific community, leading to high-quality publications in reputed international journals. His doctoral research on antibiotic production through solid-state fermentation was highly regarded for its potential industrial applications. He has also been acknowledged for his collaborative research on Alzheimer’s, Parkinson’s, Huntington’s disease, and metabolic disorders. With impactful publications, peer recognition, and contributions to translational science, Dr. Vastrad stands as a promising candidate for research awards and academic distinction.

Research Focus 

Dr. Basavaraj Vastrad research focuses on the intersection of biotechnology, molecular biology, and bioinformatics. His expertise lies in identifying disease-associated genes, pathways, and biomarkers through computational and next-generation sequencing data analysis. He has explored the molecular underpinnings of neurodegenerative diseases such as Alzheimer’s, Parkinson’s, Huntington’s disease, dementia, and metabolic disorders like gestational diabetes mellitus. His doctoral research emphasized antibiotic production through solid-state fermentation, while his M. Pharm training provided strong grounding in microbial, enzymatic, and cell culture techniques. Currently, his bioinformatics-driven studies integrate systems biology with molecular docking to propose potential therapeutic compounds for complex human diseases.

Publication Top Notes

Molecular mechanisms underlying gliomas and glioblastoma pathogenesis revealed by bioinformatics analysis of microarray data

Optimization and production of neomycin from different agro industrial wastes in solid state fermentation

Identification of candidate biomarkers and therapeutic agents for heart failure by bioinformatics analysis

Bioinformatics analyses of significant genes, related pathways, and candidate diagnostic biomarkers and molecular targets in SARS-CoV-2/COVID-19

Identification of crucial candidate genes and pathways in glioblastoma multiform by bioinformatics analysis

Optimization of process parameters for rifamycin b production under solid state fermentation from Amycolatopsis mediterranean MTCC14

Identification of potential mRNA panels for severe acute respiratory syndrome coronavirus 2 (COVID-19) diagnosis and treatment using microarray dataset and bioinformatics methods

Identification of key pathways and genes in polycystic ovary syndrome via integrated bioinformatics analysis and prediction of small therapeutic molecules

Identification of important invasion and proliferation related genes in adrenocortical carcinoma

Investigation of candidate genes and mechanisms underlying obesity associated type 2 diabetes mellitus using bioinformatics analysis and screening of small drug molecules

Identification of candidate biomarkers and pathways associated with type 1 diabetes mellitus using bioinformatics analysis

Identification of key pathways and genes in obesity using bioinformatics analysis and molecular docking studies

Analysis of differentially expressed genes in coronary artery disease by integrated microarray analysis

Conclusion

Based on his strong academic foundation, diverse methodological expertise, and influential research publications in neurodegenerative, metabolic, and reproductive disorders, Dr. Basavaraj Vastrad is a highly suitable candidate for the Research for Best Innovation Award. His pioneering bioinformatics-driven approaches to unravel disease mechanisms and identify biomarkers showcase a forward-thinking vision aligned with global health challenges. With additional focus on translational research and clinical applications, he has the potential to emerge as a leading innovator in pharmaceutical biotechnology and precision medicine.

Tiziana Russo Spena | Pharmaceutical Biotechnology | Best Paper Award

Published on by Top Pharmaceutical

Tiziana Russo Spena | Pharmaceutical Biotechnology | Best Paper Award

Prof. Tiziana Russo Spena, Dipartimento di Economia management Istituzioni, Università degli Studi di Napoli Federico II, Italy

Prof. Tiziana Russo Spena is a Full Professor of Economics and Business Management at the University of Naples Federico II 🇮🇹. She holds a Ph.D. in Business Economics and specializes in digital health, sustainable business models, and stakeholder engagement 🔬💡. She has led multiple national and international research projects, including initiatives on blockchain in the agri-food sector, interactive robotics for aging well, and digital health services 🤖🌿. With extensive academic contributions, she plays a key role in shaping innovative business strategies and economic frameworks. 📚🏆

Publication Profile

Scopus

Education

Prof. Tiziana Russo Spena 🎓 is a distinguished Full Professor of Economics and Business Management (2022). She earned her Ph.D. in Business Economics (2002-2005) from the Faculty of Economics, University of Naples Federico II. Prior to that, she completed a Master’s in Investment Project Evaluation (2002) at the Research Centre of Urban and Territorial Management (L.U.P.T). Her academic journey began with a Degree in Business and Administration (1998), graduating with top honors (110/110 cum laude) from the same university. With a strong foundation in business and economics, she has made remarkable contributions to the field. 📚💼

Institutional And Membership

Prof. Tiziana Russo Spena 🎓 is an active member of the academic and research community, contributing to various institutional and membership activities. In 2024, she joined the Editorial Board of the International Journal of Research in Marketing and became the Coordinator of the Ph.D. Program in Management at the University of Naples Federico II. She serves as a board member of ReSER and CAISIAL, a treasurer at ReSER, and a key member of the Ateneo Commission for Internationalization. Additionally, she co-founded the Italian Blockchain National Observatory and leads advanced training courses in social media marketing and blockchain. 🔗📚

Awards

Prof. Tiziana Russo Spena 🏆 has received numerous prestigious awards for her research and contributions. In 2022, her article on COVID-19’s impact won the Highly Commended Paper award. She earned the Outstanding Paper Award (2013) for her work on store experience and co-creation. Her research on food innovation won the Best Paper Award (2013) at Lucerne University. Recognized as a Pioneer of Human Side of Service Engineering (2012), she was also a finalist in the Start Cup-Campania Competition (2011). Additionally, she received the Best Service Innovation Thinking Award (2008) and the Roberto Marrama Prize (2004). 🏅

Teaching Activities

Prof. Tiziana Russo Spena 🎓 has an extensive teaching career spanning various disciplines in business and management. Since 2019, she has been a Professor of Ethics and Management at the University of Naples Federico II. She also teaches Management (2018–present) and Marketing of Pharmaceutical Products (2012–present). Previously, she taught International Management (2013–2019), Retail Management (2013–2016), and International Marketing (2016–2018). She was a Visiting Professor in Brazil (2013) and an Assistant Professor at Magna Graecia University (1994–2012). Her contributions span agrifood, non-profits, and international trade, shaping future business leaders. 📚

Research Focus

Professor Tiziana Russo Spena specializes in service innovation, digital transformation, and customer experience, particularly in emerging digital ecosystems. Her research focuses on topics such as the phygital customer journey 🛍️📱, human-robot collaboration 🤖🤝, the metaverse in business and marketing 🌐🎭, and technology-enabled value co-creation 💡🔗. She explores how smart technologies and AI-driven solutions enhance consumer engagement and service management. Additionally, she investigates the role of innovation ecosystems in cultural heritage 🏛️📜. Her interdisciplinary approach integrates marketing, digital services, and technology management, shaping the future of service design and digital customer interactions.

Publication Top Notes

Unravelling the customer journey: A conceptual framework and research agenda

Phygital customer journey: a practice-based approach

A system and learning perspective on human–robot collaboration

Experimenting on the metaverse to foster innovation

HCAI-Based Service Provision for an Engaged University

Agencement of onlife and phygital: smart tech–enabled value co-creation practices

Innovative value propositions in the fashion metaverse

Addressing Socio-Material Issues for an Emerging Innovation Ecosystem: Insights From Cultural Heritage

Dr. Rahim Dehghan|Pharmaceutical Biotechnology| Best Researcher Award

Published on by Top Pharmaceutical

Dr. Rahim Dehghan|Pharmaceutical Biotechnology |Best Researcher Award|

Dr. Rahim Dehghan at mus alparslan university, Turkeys

PROFILE  

scopus

Google Sholar

 

Early Academic Pursuits 🎓

Rahim Dehghan embarked on his academic journey in the field of polymer engineering at Shiraz University, where he earned his bachelor’s degree in 2011. Driven by a deep curiosity and passion for polymer science, he pursued a master’s degree in polymer engineering at Yazd University, completing it in 2015. His master’s thesis was a significant exploration of blood-compatible membranes, a topic that laid the foundation for his future research endeavors. This period of academic training provided him with a robust understanding of polymer materials and their applications in biomedical engineering, particularly in the development of membranes for medical use.

Professional Endeavors and Research Focus 🧪

Dehghan’s professional career has been marked by a series of research positions and projects that have focused on the development and enhancement of synthetic membranes for biomedical applications. In 2016, he commenced his Ph.D. at the prestigious Iran Polymer and Petrochemical Institute, a leading center for polymer education in Iran. His doctoral research was centered on developing membranes for the separation of low-density lipoprotein (LDL), commonly known as bad cholesterol, from blood plasma. This work was groundbreaking, as it addressed critical challenges in blood purification technologies, aiming to improve the efficiency and efficacy of these processes.

During his Ph.D. studies, Dehghan worked on several key aspects of membrane engineering, including pore size optimization, morphology control, and enhancing membrane permeability. His innovative approach to membrane structural engineering was aimed at achieving high-performance membranes capable of selective separation of LDL from blood plasma, while ensuring high plasma permeability. His research contributions during this period culminated in a Ph.D. degree, awarded in 2022 with an excellent grade, reflecting the significance and quality of his work.

Contributions and Research Focus 🌍

Dehghan’s research has had a profound impact on the field of membrane science, particularly in the development of membranes for biomedical applications. His work on LDL separation has opened new avenues for research in blood purification technologies, with potential applications in treating cardiovascular diseases and other conditions where blood purification is critical. He has also contributed to the field of microfiltration membranes for plasmapheresis, a process used to separate plasma from blood cells. His recent work has successfully developed a microfiltration membrane capable of simultaneously separating LDL and blood cells from whole blood, a significant advancement in this area.

In addition to his academic research, Dehghan has played a crucial role in the industrial application of his findings. As a researcher at the Iranian Polymer and Petrochemical Institute and a senior researcher at D.G.DENA Co., he has applied his expertise to the development of biomedical devices, including hydrogels and gels for wound care. His work in these roles has involved the application of advanced polymer science to address real-world challenges in medical device manufacturing.

Accolades and Recognition 🏆

Throughout his academic and professional career, Dehghan has received numerous accolades that highlight his contributions to the field of polymer engineering. One of his early achievements was acquiring the 8th rank in the national Ph.D. entrance exam in Iran in 2016, a highly competitive examination with over 400 participants. This accomplishment not only earned him a prestigious scientific award but also set the stage for his successful academic career.

His research has been widely recognized and published in several leading international journals, including the Journal of Membrane Science and Separation and Purification Technology. These publications have not only disseminated his findings to the broader scientific community but have also established him as a leading researcher in the field of polymer-based membrane technologies.

Impact and Influence 🌟

Dehghan’s work has had a significant impact on both the academic and industrial sectors. His research on membrane technologies has provided new insights into the design and development of high-performance membranes for medical applications. These contributions are particularly important in the context of blood purification technologies, where efficient and selective separation processes are critical for patient outcomes.

In the industrial sphere, his work as a consultant and researcher has directly influenced the development of new medical devices, particularly in the area of wound care. His expertise in polymer science has been instrumental in advancing the capabilities of these devices, ensuring they meet the stringent requirements of biomedical applications.

Legacy and Future Contributions 🌠

Looking ahead, Rahim Dehghan’s contributions to the field of polymer engineering and membrane science are poised to leave a lasting legacy. His work has already set new standards for the development of synthetic membranes, particularly in the biomedical field. As he continues to explore new research opportunities, particularly in the field of blood purification membranes such as hemodialysis and hemodiafiltration, his impact on the field is expected to grow.

🎓Publication 

Dextran sulfate bulk and surface-modified microfiltration membrane for simultaneous blood plasma harvesting and low-density lipoprotein removal during plasmapheresis

  • Authors   :Dehghan, R., Barzin, J., Carbonell, R.G., Ghaderi Jafarbeigloo, H., Kordkatooli, Z.
  • Journal    :Journal of Membrane Science
  • Year         :2024

Evaluation of solubility parameters and relative energy difference (RED) on the preparation of polysulfone/polyethylene glycol membrane: A study on the casting solution and coagulation bath

Membrane patterning through horizontally aligned microchannels developed by sulfated chopped carbon fiber for facile permeability of blood plasma components in low-density lipoprotein apheresis

High cut-off membrane: evaluation of pore collapse and the synergistic effect of low and high molecular weight polyvinylpyrrolidone

Low density lipoprotein (LDL) apheresis from blood plasma via anti-biofouling tuned membrane incorporated with graphene oxide-modified carrageenan